How to License a Patent: A Founder's Guide

A patent gives you the right to exclude others from using your invention — but exclusion isn't the only way to create value from it. Licensing lets you grant others the right to practice your invention in exchange for payment, while you retain ownership of the underlying IP.

For founders and inventors who lack the capital or manufacturing capacity to bring a product to market alone, licensing can be the difference between a patent that earns and a patent that just costs maintenance fees.

Types of licenses

Exclusive license — Only one licensee can practice the patent. You cannot license it to anyone else, and depending on the agreement, you may not be able to practice it yourself. An exclusive license is essentially an assignment of rights for the term of the agreement. Exclusive licenses command the highest royalties because the licensee has no competitors using the same technology.

Non-exclusive license — Multiple companies can license the same patent simultaneously. Each pays royalties, but none has competitive exclusivity. Lower per-licensee payments, but the aggregate can exceed what a single exclusive deal generates, especially for widely applicable technologies.

Field-of-use license — A license restricted to a specific application, geography, or market segment. Example: an exclusive license for medical imaging devices, while you retain the right to license the same patent for industrial inspection equipment. This approach maximizes revenue by segmenting the market — but it requires that the technology genuinely applies across distinct, non-overlapping fields.

Cross-license — Two companies license their respective patents to each other, often without cash payment. Common in industries with dense patent thickets (semiconductors, smartphones, standards-essential patents). Cross-licenses let companies operate without infringement liability rather than generating cash revenue.

How royalties are structured

Running royalty — A percentage of revenue (or a per-unit fee) paid on sales of licensed products. Running royalties align licensor incentives with licensee success — you earn more if the product does well. Typical rates vary enormously by industry: 1–5% for manufacturing patents, 2–10% for software patents, 10–25% for pharmaceutical patents, and occasionally higher for blockbuster drugs where alternatives don't exist.

Lump sum — A one-time payment for a perpetual or term license. Simpler to administer, lower ongoing transaction costs, but the licensor bears the risk of the technology performing better than expected (and conversely, the licensee bears the risk of underperformance). Common when future revenue is hard to predict or audit.

Minimum annual royalty — A floor payment that keeps the license from going dormant. If you grant an exclusive license to a company that never commercially launches the product, you still receive a minimum payment. Without this, you could be locked into an exclusive deal with zero revenue while the licensee sits on the technology.

Milestone payments — Common in pharmaceutical and biotech licensing: payments triggered by regulatory events (IND filing, Phase II completion, FDA approval) rather than sales. Useful when commercialization has a long, uncertain timeline.

What a license agreement includes

A well-drafted patent license agreement covers at minimum:

Grant clause — Defines exactly what rights are being licensed: which patents (by number), which patent families (continuations, divisionals, foreign equivalents), which field of use, which geography, and whether the license is exclusive or not.

Royalty rate and payment terms — The rate, the royalty base (net sales? gross revenue? per unit?), payment frequency (quarterly is standard), and late payment penalties.

Audit rights — The right to audit the licensee's royalty calculations, usually up to once per year with 30 days' notice. Without audit rights, you have no mechanism to verify you're being paid correctly.

Sublicensing rights — Can the licensee sublicense to third parties? If so, on what terms, and do you share in sublicensing revenue?

Improvement rights — Who owns improvements the licensee makes to the licensed technology? This is a significant negotiating point — some licensees insist on owning their improvements; licensors often want a license-back to access those improvements.

Representations and warranties — What you're warranting about the patent (that you own it, that you haven't already exclusively licensed it, that you're not aware of validity challenges). Note: warranty of non-infringement is something you almost certainly should not grant — you can't guarantee your patent covers what the licensee needs it to cover, and infringement analysis is uncertain.

Termination provisions — When either party can terminate, what triggers termination (non-payment, breach), and what happens to sublicenses if the main license terminates.

Finding licensees

Identifying who benefits from your patent is the first analytical task. Ask: who is currently operating in the space covered by my claims? Who would gain competitive advantage from exclusive access?

Practical channels:

• Industry conferences and trade shows — Direct contact with business development professionals
• Patent brokers — Specialists who maintain relationships with potential licensees and buyers in specific technology areas. They typically take 20–30% of deal value but can access buyers you'd never reach independently
• Licensing marketplace platforms — Ocean Tomo, IAM Market, and similar platforms list patents available for licensing or sale
• Cold outreach — A letter from a patent attorney to the VP of IP or General Counsel at relevant companies, explaining the patent and the licensing opportunity, is more effective than it sounds. Business development is a numbers game.

Valuation before you negotiate

You cannot negotiate effectively without a baseline estimate of what the patent is worth. Valuation approaches include:

Comparable transactions — What have similar patents in this technology area licensed for? Patent licensing databases (Royalty Source, ktMINE, IAM) contain transaction data.

Income approach — What royalty stream would the patent generate over its remaining term, discounted to present value at an appropriate discount rate?

Rule of 25% — A rough starting point: the licensor receives approximately 25% of the operating profit the licensee earns from the licensed technology. This is a heuristic, not a rule, but it's a useful anchor for early negotiations.

The attorney disclaimer

Patent licensing agreements are legally complex, and the stakes of getting them wrong — locking yourself into an exclusive deal at too-low royalties, granting rights you didn't intend to grant, failing to preserve enforcement options — are high. Use an IP attorney who specializes in licensing transactions. The legal cost of drafting and negotiating a licensing agreement (typically $5,000–$20,000 for a standard deal) is a small fraction of the value of the deal itself.

Before you explore licensing options, use the PatentBrief idea checker to understand the patent landscape around your technology.

PatentBrief is not a law firm. Nothing here is legal advice. Consult a qualified IP attorney before entering any patent licensing agreement.